Cargando…
Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016559/ http://dx.doi.org/10.1186/1471-2210-10-S1-A47 |
| _version_ | 1782195772354199552 |
|---|---|
| author | Bauer, Martin Zeitlinger, Markus Matzneller, Peter Stanek, Johann Lackner, Edith Wadsak, Wolfgang Müller, Markus Langer, Oliver |
| author_facet | Bauer, Martin Zeitlinger, Markus Matzneller, Peter Stanek, Johann Lackner, Edith Wadsak, Wolfgang Müller, Markus Langer, Oliver |
| author_sort | Bauer, Martin |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3016559 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-30165592011-01-07 Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET Bauer, Martin Zeitlinger, Markus Matzneller, Peter Stanek, Johann Lackner, Edith Wadsak, Wolfgang Müller, Markus Langer, Oliver BMC Pharmacol Meeting Abstract BioMed Central 2010-11-16 /pmc/articles/PMC3016559/ http://dx.doi.org/10.1186/1471-2210-10-S1-A47 Text en Copyright ©2010 Langer et al; licensee BioMed Central Ltd. |
| spellingShingle | Meeting Abstract Bauer, Martin Zeitlinger, Markus Matzneller, Peter Stanek, Johann Lackner, Edith Wadsak, Wolfgang Müller, Markus Langer, Oliver Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET |
| title | Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET |
| title_full | Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET |
| title_fullStr | Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET |
| title_full_unstemmed | Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET |
| title_short | Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET |
| title_sort | dose-response assessment of tariquidar for inhibition of p-glycoprotein at the human blood-brain barrier using (r)-[(11)c]verapamil pet |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016559/ http://dx.doi.org/10.1186/1471-2210-10-S1-A47 |
| work_keys_str_mv | AT bauermartin doseresponseassessmentoftariquidarforinhibitionofpglycoproteinatthehumanbloodbrainbarrierusingr11cverapamilpet AT zeitlingermarkus doseresponseassessmentoftariquidarforinhibitionofpglycoproteinatthehumanbloodbrainbarrierusingr11cverapamilpet AT matznellerpeter doseresponseassessmentoftariquidarforinhibitionofpglycoproteinatthehumanbloodbrainbarrierusingr11cverapamilpet AT stanekjohann doseresponseassessmentoftariquidarforinhibitionofpglycoproteinatthehumanbloodbrainbarrierusingr11cverapamilpet AT lackneredith doseresponseassessmentoftariquidarforinhibitionofpglycoproteinatthehumanbloodbrainbarrierusingr11cverapamilpet AT wadsakwolfgang doseresponseassessmentoftariquidarforinhibitionofpglycoproteinatthehumanbloodbrainbarrierusingr11cverapamilpet AT mullermarkus doseresponseassessmentoftariquidarforinhibitionofpglycoproteinatthehumanbloodbrainbarrierusingr11cverapamilpet AT langeroliver doseresponseassessmentoftariquidarforinhibitionofpglycoproteinatthehumanbloodbrainbarrierusingr11cverapamilpet |